• Adaptapack's case packer and other design IP has been purchased by Packaging Partners.
    Adaptapack's case packer and other design IP has been purchased by Packaging Partners.
Close×

Packaging Partners has purchased the assets and design IP of Adaptapack, the robotic case packing technology business developed by Walls Machinery, which went into administration late last year.

“We’ve been looking for an opportunity to enter the intermittent RSC case packing sector for a while now, as it’s very complementary to our other interests in the packaging machinery space,” said Phil Biggs, Packaging Partners director. “These flexible packers are particularly suited to low- to medium-speed food and dairy applications, for both rigid and flexible primary packs. They are ideal for market opportunities we’ve identified in both Australia and also Asia.”

Packaging Partners has appointed Foodmach as the Australian distribution agent for the extensive product range.

“Our team at Foodmach has extensive technical knowledge of case packing, and so along with our robotic palletising, conveying, line control and Robopac stretch wrapping technologies, we can now supply seamless and fully integrated end-of-line packaging solutions,” said Earle Roberts, Foodmach CCO.

Packaging Partners confirmed the Adaptapack brand will be discontinued, however, the company will support the extensive installed base of machines in Australia and Asia via its distribution partners.

Food & Drink Business

A coalition of global food waste organisations has called on the COP31 presidency to turn existing commitments on food loss and waste into funded policy. It’s a move with direct relevance to Australia, which holds the presidency of negotiations for this year’s climate summit.

Inghams has placed its Western Australian farms and processing operations into complete lockdown after authorities confirmed Australia’s first detection of the high pathogenicity H5 avian influenza strain that has spread globally since 2020.

The a2 Milk Company is set to return $300 million to shareholders after securing Chinese regulatory approval that finalises its acquisition of the a2 Pokeno infant formula facility in New Zealand.